Atrial Fibrillation Trial, Recruiting NCT06263608 Sponsor: University Hospital, Antwerp Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06263608
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with atrial fibrillation (an irregular heartbeat) — either the kind that comes and goes (paroxysmal) or the kind that lasts longer (persistent) — confirmed by a heart tracing test (ECG)
  • People who experience noticeable symptoms from their atrial fibrillation, such as feeling the irregular heartbeat, shortness of breath, or reduced ability to do everyday activities
  • People who are older than 18 years of age
  • People who own a smartphone that is compatible with both the Fitbit and FibriCheck apps (meaning a phone running a recent version of Apple iOS or Android)
  • People who are able to read and sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People whose atrial fibrillation has been classified as permanent, or who have only atrial flutter (a related but different type of irregular heartbeat)
  • People who have recently had, or previously had, a sleep study test (called polysomnography)
  • People who are currently using, or have previously used, a breathing machine during sleep (such as CPAP, BiPAP, or ASV devices)
  • People who have a cognitive impairment (such as difficulties with memory or thinking)
  • People who are unable to speak or fully understand Dutch
  • People whose heart depends entirely on a pacemaker to maintain its rhythm

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hein Heidbuchel, MD, PhD, University Hospital of Antwerp

Phone: +32 3 821 33 06

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Antwerp
Registry
ClinicalTrials.gov
Start date
23 February 2024
Est. completion
1 February 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

AF burden before and after CPAP treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov